Literature DB >> 2441163

Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system.

P Smits, P Boekema, R De Abreu, T Thien, A van 't Laar.   

Abstract

A randomized, double-blind and placebo-controlled study was performed in 10 normotensive male subjects to analyze a possible antagonism between caffeine and adenosine with respect to their effects on the cardiovascular system in humans. Caffeine alone, 250 mg intravenously (i.v.), increased blood pressure by 9/12 mm Hg, and resulted in a fall of heart rate (HR) of 3 beats/min. Plasma epinephrine (E) rose by 114% after caffeine. Adenosine alone, in an increasing dose of 0.04-0.16 mg/kg/min, induced an increase in systolic blood pressure (SBP) (17 mm Hg), and HR (33 beats/min), a moderate fall in diastolic blood pressure (DBP) (-4 mm Hg), and no change of mean arterial pressure (MAP). At the highest adenosine infusion rate, forearm blood flow, skin temperature (ST), and transcutaneous oxygen tension were lowered, whereas plasma (nor)epinephrine was increased 227.2 and 215.9%, respectively. Adenosine infusion after caffeine induced comparable effects, but the fractional adenosine-induced changes of SBP, HR, plasma catecholamines, plasma renin activity (PRA), and aldosterone all were significantly reduced by previous administration of caffeine. Our results indicate an antagonism between caffeine and adenosine in humans, which may support the suggestion that some circulatory effects of caffeine are caused by an interaction with endogenous adenosine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441163     DOI: 10.1097/00005344-198708000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  18 in total

1.  The effect of caffeine on glucose kinetics in humans--influence of adrenaline.

Authors:  Danielle S Battram; Terry E Graham; Erik A Richter; Flemming Dela
Journal:  J Physiol       Date:  2005-09-08       Impact factor: 5.182

2.  The effects of caffeine on blood pressure and heart rate: A review.

Authors:  P J Green; R Kirby; J Suls
Journal:  Ann Behav Med       Date:  1996-09

Review 3.  Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.

Authors:  Kristina E Powles; Renee C Hessian; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

4.  Caffeine Enhances Heart Rate Variability in Middle-Aged Healthy, But Not Heart Failure Subjects.

Authors:  Catherine F Notarius; John S Floras
Journal:  J Caffeine Res       Date:  2012-06

5.  Coffee does not modify postprandial glycaemic and insulinaemic responses induced by carbohydrates.

Authors:  Katja A Hätönen; Jarmo Virtamo; Johan G Eriksson; Harri K Sinkko; Iris Erlund; Pekka Jousilahti; Jaana M Leiviskä; Liisa M Valsta
Journal:  Eur J Nutr       Date:  2011-10-25       Impact factor: 5.614

6.  Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine.

Authors:  A F Jacobson; M D Cerqueira; V Raisys; S Shattuc
Journal:  Eur J Nucl Med       Date:  1994-01

7.  Caffeine tolerance is incomplete: persistent blood pressure responses in the ambulatory setting.

Authors:  Noha H Farag; Andrea S Vincent; Bong Hee Sung; Thomas L Whitsett; Michael F Wilson; William R Lovallo
Journal:  Am J Hypertens       Date:  2005-05       Impact factor: 2.689

8.  [Effect of caffeine on myocardial blood flow during pharmacological vasodilation].

Authors:  J P Wielepp; E Fricke; D Horstkotte; W Burchert
Journal:  Z Kardiol       Date:  2005-02

9.  Duration of caffeine abstention influences the acute blood pressure responses to caffeine in elderly normotensives.

Authors:  R A Haigh; G D Harper; M Fotherby; J Hurd; I A Macdonald; J F Potter
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Respiratory stimulant effects of adenosine in man after caffeine and enprofylline.

Authors:  P Smits; J Schouten; T Thien
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.